Canada Pension Plan Investment Board grew its holdings in shares of Akorn, Inc. (NASDAQ:AKRX) by 47.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 205,000 shares of the company’s stock after purchasing an additional 66,000 shares during the period. Canada Pension Plan Investment Board owned approximately 0.16% of Akorn worth $6,804,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Public Employees Retirement Association of Colorado lifted its holdings in shares of Akorn by 0.8% during the 2nd quarter. Public Employees Retirement Association of Colorado now owns 19,534 shares of the company’s stock valued at $655,000 after purchasing an additional 158 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in shares of Akorn by 1.4% during the 2nd quarter. Pacer Advisors Inc. now owns 12,889 shares of the company’s stock valued at $432,000 after purchasing an additional 180 shares during the last quarter. Great West Life Assurance Co. Can lifted its holdings in shares of Akorn by 0.7% during the 2nd quarter. Great West Life Assurance Co. Can now owns 51,847 shares of the company’s stock valued at $1,738,000 after purchasing an additional 340 shares during the last quarter. State Treasurer State of Michigan increased its position in shares of Akorn by 1.4% in the 2nd quarter. State Treasurer State of Michigan now owns 35,900 shares of the company’s stock valued at $1,204,000 after acquiring an additional 500 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Akorn by 22.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,228 shares of the company’s stock valued at $108,000 after acquiring an additional 599 shares during the period. Hedge funds and other institutional investors own 68.67% of the company’s stock.

Shares of Akorn, Inc. (NASDAQ AKRX) opened at $33.21 on Monday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 3.17 and a current ratio of 4.16. Akorn, Inc. has a 12 month low of $17.61 and a 12 month high of $34.00. The stock has a market cap of $4,153.60, a PE ratio of 20.63, a PEG ratio of 1.98 and a beta of 1.33.

Several equities analysts recently issued reports on the company. Jefferies Group LLC reissued a “hold” rating and issued a $34.00 target price on shares of Akorn in a research report on Wednesday, July 19th. Royal Bank Of Canada set a $34.00 target price on Akorn and gave the company a “hold” rating in a research report on Sunday, July 30th. BidaskClub downgraded Akorn from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. TheStreet downgraded Akorn from a “b-” rating to a “c” rating in a research report on Tuesday, August 1st. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $34.00 target price on shares of Akorn in a research report on Thursday, August 10th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $29.38.

ILLEGAL ACTIVITY WARNING: “Canada Pension Plan Investment Board Has $6.80 Million Stake in Akorn, Inc. (AKRX)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/11/13/canada-pension-plan-investment-board-has-6-80-million-stake-in-akorn-inc-akrx.html.

Akorn Company Profile

Akorn Inc (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health.

Institutional Ownership by Quarter for Akorn (NASDAQ:AKRX)

Receive News & Stock Ratings for Akorn Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akorn Inc. and related stocks with our FREE daily email newsletter.